(B)SUBMISSION OF MANUSCRIPT

1.       COVERING LETTER

2.       MANUSCRIPT

3.       AUTHOR'S CONTRIBUTIONS

4.       UNDERTAKING BY AUTHOR(S)

5.       COPYRIGHT TRANSFER AGREEMENT

(C)PROOFS AND REPRINTS

Undertaking by Author(s)

Copyright Transfer Agreement

manuscript submission check list

SCOPE

 The Indian Journal of Medical Research (IJMR) is a biomedical journal with international circulation. It publishes original communications of biomedical research that advances or illuminates medical science or that educates the journal readers. It is issued monthly, in two volumes per year.

 Manuscripts dealing with clinical aspects will be considered for publication, provided they contain results of original investigations. Articles need to be of general interest – e.g., they cross the boundaries of specialities or are of sufficient novelty and importance that the journal’s readers, whatever their speciality, should be made aware of the findings. Research papers reporting original research, review articles, correspondence on published articles will also be considered. Papers of routine nature which are merely records of interesting cases as also those dealing with modifications of routine methodology will not be encouraged. Further, serialization of articles by the same author(s) into various parts (1,2,3 etc.) is strongly discouraged. In such cases the authors are advised to submit independent papers with self-sufficient titles and text.

 The IJMR strongly discourages duplication/reduplication of data already published in other journals (even when certain cosmetic changes/additions are made). If and when duplication is detected after publishing in IJMR, the journal will be forced to ‘retract’ such articles. Articles based on work carried out in private nursing homes and other non-recognized hospitals/research institutes will be discouraged.

 All papers submitted to IJMR are subject to peer review process. All accepted papers will be suitably edited before publication.

SUBMISSION OF MANUSCRIPT

 All manuscripts submitted for publication to the IJMR should include the following:

1. COVERING LETTER

 A covering letter which could explain why the paper should be published in the IJMR, rather than a specialist journal. One of the authors could be identified as the corresponding author of the paper, who would be responsible for the contents of the paper as also answer.

 2. MANUSCRIPT

 Manuscripts can be submitted by e-mail and also  in a CD in MS Word (in addition to the hard copies). Typescripts in triplicate should be sent to the Editor, The Indian Journal of Medical Research, Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi-110029 (India).

  Authors are advised to see a recent issue of the journal to get familiar with the format adopted on various elements of a paper.

 Manuscripts should be presented in as concise a form as possible, typewritten in double space on one side of a good quality bond paper (21.0 x 29.7 cms ). Pages should be numbered consecutively and the contents arranged in the following order:- Title; Name(s) of the author(s); Department(s) and Institution(s); Abstract; Key words; Introduction; Material & Methods; Results; Discussion; Acknowledgement; and References. Abstract, Tables and legends for Figures should be typed on separate sheets and not in continuation of the main text.

In manuscripts submitted by e-mail the text should be typed in MS-Word and Figures/Photographs in JPEG or GIF format.

 Title

Title of the article should be short, continuous (broken or hyphenated titles are not acceptable) and yet sufficiently descriptive and informative so as to be useful in indexing and information retrieval. A short running title not exceeding 6-7 words may also be provided.

Abstract

All manuscripts should have a structured abstract (of about 250 words) with subheadings  of background & objectives, methods, results ,interpretation and conclusions. Abstract should be brief and indicate the scope and significant results of the paper. It should only highlight the principal findings and conclusions so that it can be used by abstracting services without modification. Conclusions and recommendations not found in the text of the articles should not be inserted in the Abstract. A set of suitable key words arranged alphabetically may be provided.

Introduction

Introduction should be brief and state precisely the scope of the paper. Review of the literature should be restricted to reasons for undertaking the present study and provide only the most essential background.

Material & Methods

The nomenclature, the source of material and equipment used, with the manufacturers details in parenthesis, should be clearly mentioned. The procedures adopted should be explicitly stated to enable other workers to reproduce the results, if necessary. New methods may be described in sufficient detail and indicating their limitations. Established methods can be just mentioned with authentic references and significant deviations, if any given, with reasons for adopting them. While reporting experiments on human subjects and animals, it should be clearly mentioned that procedures followed are in acordance with the ethical standards laid down by the national bodies or organizations of the particular country. For example, for research carried out in India on human subjects, the ICMR’s Ethical guidelines for biomedical research on human subjects  (2000) should be adhered  to. Similarly, for experiments on laboratory animals the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) should be followed. Adequate information should be provided on the care and use of laboratory animals, source of animals, strain, age, sex, housing and nutrition etc. Whenever needed, appropriate certification should be provided at the time of submission of the manuscripts. The drugs and chemicals used should be precisely identified, including generic name(s), dosage(s) and route(s) of administration.

The statistical analysis done and statistical significance of the findings when appropriate, should be mentioned. Unless absolutely necessary for a clear understanding of the article, detailed description of statistical treatment may be avoided. Articles based heavily on statistical considerations, however, need to give details particularly when new or uncommon methods are employed. Standard and routine statistical methods employed need to give only authentic references.

Results

Only such data as are essential for understanding the discussion and main conclusions emerging from the study should be included. The data should be arranged in unified and coherent sequence so that the report develops clearly and logically. Data presented in tables and figures should not be repeated in the text. Only important observations need to be emphasized or summarised. The same data should not be presented both in tabular and graphic forms. Interpretation of the data should be taken up only under the Discussion and not under Results.

Discussion

The discussion should deal with the interpretation of results without repeating information already presented under Results. It should relate new findings to the known ones and include logical deductions. It should also mention any weaknesses of the study.

The conclusions can be linked with the goals of the study but unqualified statements and conclusions not completely supported by the data should be avoided. Claiming of priority on work that is ongoing should also be avoided. All hypotheses should, if warranted, clearly be identified as such; recommendations may be included as part of the Discussion, only when considered absolutely necessary and relevant.

Acknowledgment

Acknowledgment should be brief and made for specific scientific/technical assistance and financial support only and not for providing routine departmental facilities and encouragement or for help in the preparation of the manuscripts (including typing or secretarial assistance).

References

The total number of References should normally be restricted to a maximum of 30.

References to literature cited should be numbered consecutively and placed at the end of the manuscript. In the text they should be indicated above the line (superior). As far as possible mentioning names of author(s) under references should be avoided in text.

Articles in Journals: The titles of the journals should be abbreviated according to the style used by the Index Medicus. The list of journals indexed, published annually, in the January issue of the Index Medicus may be consulted.

 1. Standard journal article

List the first six authors followed by et al.

Halpern SD , Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

More than six authors:

Rose ME, Huerbin MB , Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

2. Organization as author

Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.

3. Both personal authors and an organization as author

Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257-61.

4. No author given

21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.

5. Article not in English

Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen. 2002;122(8):785-7.

6. Volume with supplement

Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.

7. Issue with supplement

Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6-12.

8. Volume with part

Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002;83(Pt 2):491-5.

9. Issue with part

Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.

10. Issue with no volume

Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230-8.

11. No volume or issue

Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1-6.

12. Pagination in roman numerals

Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002;16(2):iii-v.

13. Type of article indicated as needed

Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy [letter]. Eur Respir J. 2002;20(1):242.

Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002;66 Suppl 1:S105.

14. Article containing retraction

Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2002;63(2):169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2000;61(12):909-11.

15. Article retracted

Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000;61(12):909-11. Retraction in: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2002;63(2):169.

16. Article republished with corrections

Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol. 2002;188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001;183(1-2):123-6.

17. Article with published erratum

Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther. 2000;22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther 2001;23(2):309.

18. Article published electronically ahead of the print version

Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15;100(10):3828-31. Epub 2002 Jul 5.

Books and Other Monographs

19. Personal author(s)

Murray PR, Rosenthal KS , Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis : Mosby; 2002.

20. Editor(s), compiler(s) as author

Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York : McGraw-Hill; 2002.

21. Author(s) and editor(s)

Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.

22. Organization(s) as author

Royal Adelaide Hospital ; University of Adelaide , Department of Clinical Nursing. Compendium of nursing research and practice development, 1999-2000. Adelaide (Australia): Adelaide University ; 2001.

23. Chapter in a book

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York : McGraw-Hill; 2002. p. 93-113.

24. Conference proceedings

Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK . New York : Springer; 2002.

25. Conference paper

Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland . Berlin : Springer; 2002. p. 182-91.

26. Scientific or technical report

Issued by funding/sponsoring agency:

Yen GG (Oklahoma State University , School of Electrical and Computer Engineering, Stillwater, OK ). Health monitoring on vibration signatures. Final report. Arlington (VA): Air Force Office of Scientific Research (US), Air Force Research Laboratory; 2002 Feb. Report No.: AFRLSRBLTR020123. Contract No.: F496209810049.

Issued by performing agency:

Russell ML, Goth-Goldstein R, Apte MG, Fisk WJ. Method for measuring the size distribution of airborne Rhinovirus. Berkeley (CA): Lawrence Berkeley National Laboratory, Environmental Energy Technologies Division; 2002 Jan. Report No.: LBNL49574. Contract No.: DEAC0376SF00098. Sponsored by the Department of Energy.

27. Dissertation

Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant (MI): Central Michigan University ; 2002.

28. Patent

Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug 1.

Other Published Material

29. Newspaper article

Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2 (col. 4).

30. Audiovisual material

Chason KW, Sallustio S. Hospital preparedness for bioterrorism [videocassette]. Secaucus (NJ): Network for Continuing Medical Education; 2002.

31. Legal Material

Public law:
Veterans Hearing Loss Compensation Act of 2002, Pub. L. No. 107-9, 115 Stat. 11 (May 24, 2001).

Unenacted bill:
Healthy Children Learn Act, S. 1012, 107th Cong., 1st Sess. (2001).

Code of Federal Regulations:
Cardiopulmonary Bypass Intracardiac Suction Control, 21 C.F.R. Sect. 870.4430 (2002).

Hearing:
Arsenic in Drinking Water: An Update on the Science, Benefits and Cost: Hearing Before the Subcomm. on Environment, Technology and Standards of the House Comm. on Science, 107th Cong., 1st Sess. (Oct. 4, 2001).

32. Map

Pratt B, Flick P, Vynne C, cartographers. Biodiversity hotspots [map]. Washington : Conservation International; 2000.

33. Dictionary and similar references

Dorland's illustrated medical dictionary. 29th ed. Philadelphia : W.B. Saunders; 2000. Filamin; p. 675.

Unpublished Material

34. In press

(Note: NLM prefers "forthcoming" because not all items will be printed.)

Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A. In press 2002.

Electronic Material

35. CD-ROM

Anderson SC , Poulsen KB. Anderson 's electronic atlas of hematology [CD-ROM]. Philadelphia : Lippincott Williams & Wilkins; 2002.

36. Journal article on the Internet

Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm

37. Monograph on the Internet

Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington : National Academy Press; 2001 [cited 2002 Jul 9]. Available from: http://www.nap.edu/books/0309074029/html/.

38. Homepage/Web site

Cancer-Pain.org [homepage on the Internet]. New York : Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/.

39. Part of a homepage/Web site

American Medical Association [homepage on the Internet]. Chicago : The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html

40. Database on the Internet

Open database:
Who's Certified [database on the Internet]. Evanston (IL): The American Board of Medical Specialists. c2000 - [cited 2001 Mar 8]. Available from: http://www.abms.org/newsearch.asp

Closed database:
Jablonski S. Online Multiple Congential Anomaly/Mental Retardation (MCA/MR) Syndromes [database on the Internet]. Bethesda (MD): National Library of Medicine (US). c1999 [updated 2001 Nov 20; cited 2002 Aug 12]. Available from: http://www.nlm.nih.gov/mesh/jablonski/syndrome_title.html

41. Part of a database on the Internet

MeSH Browser [database on the Internet]. Bethesda (MD): National Library of Medicine (US); 2002 - [cited 2003 Jun 10]. Meta-analysis; unique ID: D015201; [about 3 p.]. Available from: http://www.nlm.nih.gov/mesh/MBrowser.html Files updated weekly.

MeSH Browser [database on the Internet]. Bethesda (MD): National Library of Medicine (US); 2002 - [cited 2003 Jun 10]. Meta-analysis; unique ID: D015201; [about 3 p.]. Available from: http://www.nlm.nih.gov/mesh/MBrowser.html  Files updated weekly.

Tables

Tables should be typed separately and numbered consecutively with Roman numerals (I, II, III, etc). They should bear brief title and column headings should also be short. Units of measurement should be abbreviated and placed below the headings. Statistical measurement variations such as SD and SE should be identified. Inclusion of structural formule in Tables should be avoided. Also, Tables should not be submitted as photographs.

Illustrations

Three sets of illustrations (one set original and two copies) should be submitted, either as hard copies or electronically as TIFF file, numbered consecutively in Arabic numerals.

Line drawings should be made on good quality tracing paper of Bristol board. Letters, numbers and symbols should be clear in the figures and of sufficient size, so that when reduced, they could be accommodated in single column (8.5 cm) or double column (17.0 x 21.0 cm) without loss in clarity. Titles and explanation of symbols in the legends for illustrations, should be typed on separate pages.

Photographs, to be submitted in duplicate, should be unmounted and numbered consecutively. The title of the paper and authors name(s) and `Top' indicated with an arrow should be pencilled on the back of the photographs. The pictures should be good quality prints on glossy paper showing sufficient total contrast. Their sizes should conform to single (8.5 x 21.0 cm) or double (17.0 x 21.0 cm) column sizes. All the illustrations must be protected by thick card board packing against damages during transit.

Photomicrographs should have internal scale markers regarding details of magnification to facilitate reduction in size in final print. Symbols, arrows and letters used in the photomicrographs should contrast with the background. Otherwise, the same may be indicated on the copies only which will be transferred onto the originals by the Editorial Office at the time of publication.

All published material should be acknowledged and copyright material should be submitted along with the written permission of the copyright holder.

Colour illustrations are also acceptable.

Enzyme Nomenclature

For enzymes, only the trivial names recommended by the IUPAC-IUB Commission should be used. At its first citation in the text of the paper its code number and systematic name should be indicated.

Abbreviations

Only standard abbreviations are to be used. Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers. sixth edition(1994), prepared by the Council of Biology Editors Style Manual Committee  may be consulted for additional standard abbreviations. The abbreviations should conform to the International System of Units (SI), The SI for the Health Professions (World Health Organization, Geneva ) 1977. The title of the article should not contain abbreviations. The full term for which the abbreviation stands should be given after its first use in the text unless it is a standard units of measurement. The abbreviations should be used in the text, tables and illustrations without a full stop.

 * Should not be used as an abbreviation for mole

3. AUTHORS’ CONTRIBUTIONS

 All authors are encouraged to specify their individual contributions at the bottom of the title page or on a separate page. The IJMR will not publish an item unless it has the signatures of all the authors. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is also not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.

4. UNDERTAKING BY AUTHOR(S)  Downloadable form

It is necessary that all the authors give an undertaking (in the format specified by the journal) indicating their consent to be co-authors in the sequence indicated on the title page. Each author should give his or her names as well as the address and appointment current at the time the work was done, plus a current address for correspondence including telephone and fax numbers and email address. A senior author may sign the Undertaking by Authors for a junior author who has left the institution and whose whereabouts are not known and take the responsibility.

 A paper with corporate (collective) authorship must specify the key persons responsible for the article; others contributing to the work should be recognized separately.

5. COPYRIGHT TRANSFER AGREEMENT Downloadable form

Author(s) will be asked to sign a transfer of copyright agreement, which recognizes the common interest that both journal and author(s) have in the protection of copyright. It will also allow us to tackle copyright infringements ourselves without having to go back to authors each time.

PROOFS AND REPRINTS

 Authors of accepted articles are supplied 2 sets of printer’s proofs either by post or through e-mail. Corrections on the proof should be restricted to printer’s errors only and no substantial additions/deletions should be made. No change in the names of the authors (by way of additions and deletions) is permissible at the proof stage. If there are valid reasons for such a change, after acceptance of a paper, the permission of the Editor must be sought. Fifty reprints are supplied gratis for published papers.

 Proof reading marks may be obtained  on request from the Editorial Office.

Undertaking by Authors

We, the undersigned, give an undertaking to the following effect with regard to our article entitled "

submitted for publication in the Indian Journal of Medical Research :-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

 4. I/We hereby acknowledge IJMRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-    

Authors' Names (in sequence)                                    Signature of Authors

1. ______________________________               ______________________________

2. ______________________________               ______________________________

3. ______________________________               ______________________________

4. ______________________________               ______________________________

5. ______________________________               ______________________________

6. ______________________________               ______________________________

7. ______________________________               ______________________________

8. ______________________________               ______________________________

Important

(i). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/country and whose whereabouts are not known, the senior author may sign on his/her behalf taking the responsibility.

(ii). No addition/deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be processed for publication till the issue is solved.

Copyright Transfer Agreement Form

This document must be signed by all authors and submitted with the manuscript.

COPYRIGHT TRANSFER AGREEMENT

The Indian Journal of Medical Research(IJMR) is published monthly by the Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi-110029 (India).

The IJMR and Authors hereby agree as follows: In consideration of IJMR reviewing and editing the following described work for first publication on an exclusive basis:

Title of manuscript:  ________________________________________________________

_______________________________________________________________________

The undersigned author(s) hereby assigns, conveys, and otherwise transfers all rights, title, interest, and copyright ownership of said work for publication. Work includes the material submitted for publication and any other related material submitted to IJMR. In the event that IJMR does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).

The assignment of rights to IJMR includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement, and claim copyright in said work throughout the world for the full duration of the copyright and any renewals or extensions thereof.

All accepted works become the property of IJMR and may not be published elsewhere without prior written permission from IJMR. The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.

Authors' Names (in sequence)                                    Signature of Authors

1. ______________________________               ______________________________

2. ______________________________               ______________________________

3. ______________________________               ______________________________

4. ______________________________               ______________________________

5. ______________________________               ______________________________

6. ______________________________               ______________________________

7. ______________________________               ______________________________

8. ______________________________               ______________________________

Manuscript Submission Check List

1. Covering letter
2. Undertaking by Authors signed by all authors
3. Copyright Transfer Agreement Form signed by all authors
4. Three copies of manuscript with three sets of illustrations (one original & two copies)
5. Title page
• Title of manuscript
• Full name(s) and affiliations of author(s); institution(s) and city(ies) from which work originated
• Name, address, telephone, fax numbers and e-mail address of the corresponding author.
• Running title
6. Abstract in structured format along with key words (on a separate sheet)
7. Article
8. Acknowledgment
9. References
10. Tables (on  separate sheets)